Skip to main content

Day: June 24, 2025

Jayud Global Logistics Receives $4.2 Million Government Subsidy for Charter Flight Operations

SHENZHEN, China, June 24, 2025 (GLOBE NEWSWIRE) — Jayud Global Logistics Limited (NASDAQ: JYD) (“Jayud” or the “Company”), a leading end-to-end supply chain solution provider based in Shenzhen, specializing in cross-border logistics, today announced that it has received a government subsidy of RMB 30,258,086 (approximately USD 4.2 million) from the Shenzhen Transportation Bureau. The subsidy relates to two charter flight routes operated by the Company during 2022-2023 as part of its expanded air freight services:Shenzhen-Clark Route: RMB 17.28 million Shenzhen-Davao Route: RMB 12.98 millionJayud originally applied for the cargo aircraft new route subsidies in March 2023, with the Shenzhen Transportation Bureau finalizing the subsidy amounts in March 2025 after adjusting all applications due to total...

Continue reading

Ero Copper to Release Second Quarter 2025 Operating and Financial Results on July 31, 2025

VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) — Ero Copper Corp. (TSX: ERO, NYSE: ERO) (the “Company”) will publish its second quarter 2025 operating and financial results on Thursday, July 31, 2025, after market close. The Company will host a conference call to discuss the results on Friday, August 1, 2025 at 11:30am Eastern time (8:30am Pacific time). A results presentation will be available for download via the webcast link and in the Presentations section of the Company’s website on the day of the conference call. CONFERENCE CALL DETAILSDate: Friday, August 1, 2025Time:  11:30am Eastern Time (8:30am Pacific Time)Dial In: Canada/USA Toll Free: 1-833-752-3380, International: +1-647-846-2821 Please dial in 5-10 minutes prior to the start of the call or pre-register using this link to bypass the live...

Continue reading

SciSparc Announces 1-for-21 Reverse Share Split

Following the reverse share split, the Company will have approximately 534,600 outstanding shares, out of which approximately 516,727 will be publicly held Tel Aviv, Israel, June 24, 2025 (GLOBE NEWSWIRE) — SciSparc Ltd. (“SciSparc” or the “Company”) (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that it intends to effect a one-for-twenty one (1-for-21) reverse share split (the “Reverse Share Split”) of the Company’s issued and outstanding ordinary shares, no par value per share (the “Ordinary Shares”), effective at the market open on July 3, 2025. The Ordinary Shares will continue to trade on the Nasdaq Capital Market under the existing trading symbol “SPRC” and will begin trading on...

Continue reading

Electra Announces Voting Results from 2025 Annual Meeting of Shareholders

TORONTO, June 24, 2025 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) today announced voting results of its 2025 annual general and special meeting of shareholders held today, June 24, 2025, in Toronto. A total of 5,222,899 common shares in the capital of the Company (“Common Shares”), or 29% of Electra’s issued and outstanding Common Shares were represented in person or by proxy at the meeting.  Shareholders voted in favour of all items of business put forth at the meeting, including the appointment of MNP LLP as external auditors. Each of the five director nominees listed in the management circular were elected to serve until the next annual meeting of shareholders or until their replacement is named, as set out below:Nominee Votes For % of Votes For Votes...

Continue reading

Anterix Inc. Reports Full Fiscal Year 2025 Results

WOODLAND PARK, N.J., June 24, 2025 (GLOBE NEWSWIRE) — Anterix (NASDAQ: ATEX) today announced fiscal 2025 fourth quarter and full fiscal year financial results and filed its 10-K for the year ended March 31, 2025. The Company also issued an update on its Demonstrated Intent metric which can be found on Anterix’s website at https://investors.anterix.com/events-presentations. Full Year FY2025 Financial and Operational HighlightsAppointed Scott Lang as President and Chief Executive Officer effective October 8, 2024 Appointed Thomas Kuhn as Executive Chairman of the Board in January 2025 Executed new spectrum sale agreements with Oncor Electric Delivery Company LLC (“Oncor”) for $102.5 million in June 2024 and Lower Colorado River Authority (“LCRA”) for $13.5 million in January 2025 Received milestone payments of $8.5 million from...

Continue reading

Farmers & Merchants Bancorp, Inc. Declares 2025 Second-Quarter Cash Dividend

ARCHBOLD, Ohio, June 24, 2025 (GLOBE NEWSWIRE) — The Board of Directors of Farmers & Merchants Bancorp, Inc., (Nasdaq: FMAO) the holding company of F&M Bank, with total assets of $3.39 billion at March 31, 2025, today announced that it has approved the Company’s quarterly cash dividend of $0.22125 per share. The second-quarter dividend is payable on July 20, 2025, to shareholders of record as of July 7, 2025.   For over 50 years, F&M has paid a quarterly dividend and has increased its annual dividend for 30 consecutive years reflecting the Company’s long-standing commitment to return capital to shareholders.  About Farmers & Merchants State Bank:F&M Bank is a local independent community bank that has been serving its communities since 1897. F&M Bank provides commercial banking, retail banking and other...

Continue reading

Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company’s Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease

CUE-401, a first-in-class bispecific molecule designed to induce and expand Tregs in vivo through the co-activity of transforming TGF-β and a modified variant of IL-2 BOSTON, June 24, 2025 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease, today announced it has received Pre-Investigational New Drug (Pre-IND) feedback from the U.S. Food and Drug Administration (FDA). The FDA reviewed the first-in-human trial design, including the Company’s plan for dose escalation, proposed populations and safety monitoring plan. On the basis of the FDA feedback, the Company, intends to file an IND pending completion of final IND enabling studies. CUE-401...

Continue reading

Coherent to Showcase Innovative Products, Technologies, and Thought Leadership at Laser World of Photonics 2025

SAXONBURG, Pa., June 24, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in photonics, announced today that it will showcase its new products and technologies across its photonics portfolio at Laser World of Photonics 2025, in Munich, Germany, June 24-27, Booth #3.317. Coherent will also bring expert insights thanks to its thought leaders that will present at panels and technical sessions, and other events. “Laser World of Photonics is the premier global stage for showcasing innovation in photonics, and we’re excited to demonstrate how Coherent is shaping the future of the industry—through our transformative technologies, collaborative partnerships, and thought leadership that spans our entire portfolio,” said Dr. Sanjai Parthasarathi, Chief Marketing Officer at Coherent. RECENT PRODUCT ANNOUNCEMENTSIndustry-First...

Continue reading

Coherent Launches ACE FL, an All-New, Two-Micron Fiber Laser to Address the Expanding Opportunities in Urology and Other Medical Markets

SAXONBURG, Pa., June 24, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced the launch of its ACE FL series, thulium fiber laser (TFL), engineered specifically for therapeutic medical applications – most notably for lithotripsy and benign prostatic hyperplasia (BPH) treatment. The new two-micron ACE FL system delivers superior precision, improved patient outcomes, and enhanced procedural efficiency compared to legacy laser technologies such as holmium:YAG systems. It is optimized for integration into surgical devices and laser systems used in minimally invasive procedures. “Our new thulium fiber laser is a breakthrough platform that enables medical OEMs to deliver safer, faster, and more effective treatments for kidney stones and BPH,” said Martin Seifert, Vice President, High-Power...

Continue reading

Scott Lendrum appointed Chief Executive Officer of Giga Metals Corporation

VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) — Giga Metals Corporation (TSX.V: GIGA, OTCQB: GIGGF, FSE: BRR2) (the “Company“) is pleased to announce that Scott Lendrum has been appointed Chief Executive Officer of the Company, effective July 2, and will also join the board of directors of the Company (the “Board“). Mr. Lendrum has extensive experience as an investment banker specializing in the mining sector. He has a strong track record in executing cross-border mergers and acquisitions, equity financing, and capital market transactions, and has held leadership positions at several prominent financial institutions, most recently at Paradigm Capital from 2021 – 2024, where he was Director of Investment Banking (Mining). “The appointment of Mr. Lendrum reflects our Company’s commitment...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.